What happens to cardiovascular system behind the undetectable level of HIV viremia? - Wikidata - wikimedia - TriplyDB

What happens to cardiovascular system behind the undetectable level of HIV viremia?

What happens to cardiovascular system behind the undetectable level of HIV viremia?

http://www.wikidata.org/entity/Q26749024

about

Human Immunodeficiency Virus Playing Hide-and-Seek: Understanding the TFH Cell Reservoir and Proposing Strategies to Overcome the Follicle Sanctuary Antiretroviral Treatment with Efavirenz Disrupts the Blood-Brain Barrier Integrity and Increases Stroke Severity.Factors affecting affect cardiovascular health in Indonesian HIV patients beginning ART.Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns.Antiinflammatory effects of aprepitant coadministration with cART regimen containing ritonavir in HIV-infected adults.Body fat redistribution and changes in lipid and glucose metabolism in people living with HIV/AIDS.Cardiovascular Disease in the Setting of Human Immunodeficiency Virus Infection.Distinct biomarker signatures in HIV acute infection associate with viral dynamics and reservoir size.

P2860

Q33742139-F55F2B54-ABE1-4C08-B922-2B6481DBBA71 Q37529187-05D3E1C6-FA23-4486-A62D-2B836E22A302 Q40062569-48477409-251A-46A1-8011-116B012D98ED Q40075058-0AFDC112-CAB8-4474-9F4D-1CD28C226765 Q41924104-F81B208F-E63A-47E2-883A-26BCAF763AA8 Q51251254-632B4042-88C1-47F5-9851-667E53A28C9E Q51779710-29C7CCE5-1C62-40F4-BC17-6B2B4D1A1E8D Q53818560-09AEB524-5655-4F43-ABFC-9F5A13CDF141

P2860

What happens to cardiovascular system behind the undetectable level of HIV viremia?

http://www.wikidata.org/entity/Q26749024

description

2016 nî lūn-bûn

@nan

2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

What happens to cardiovascular system behind the undetectable level of HIV viremia?

@ast

What happens to cardiovascular system behind the undetectable level of HIV viremia?

@en

What happens to cardiovascular system behind the undetectable level of HIV viremia?

@nl

type

label

What happens to cardiovascular system behind the undetectable level of HIV viremia?

@ast

What happens to cardiovascular system behind the undetectable level of HIV viremia?

@en

What happens to cardiovascular system behind the undetectable level of HIV viremia?

@nl

prefLabel

What happens to cardiovascular system behind the undetectable level of HIV viremia?

@ast

What happens to cardiovascular system behind the undetectable level of HIV viremia?

@en

What happens to cardiovascular system behind the undetectable level of HIV viremia?

@nl

P1433

Q26749024-0A733DB5-B681-4CB1-A711-BE3A26EEF54E

P1476

Q26749024-CA7F014E-7E60-434E-A236-35A76C831204

P2093

Q26749024-17B588A0-D047-47ED-A51F-1FDD3F77E44B

Q26749024-2176C254-D0FA-4F59-BA24-04C4F4A88EF0

Q26749024-25CA7F5A-5F5D-4F11-8449-349A39CFE333

Q26749024-2865BA70-FB24-4AB5-B7F6-E327B4DB553B

Q26749024-6B17E943-D476-4029-8250-59AB77F357C5

Q26749024-E41DD996-6241-4774-8700-032B7182CDC9

Q26749024-FBC917DA-F8CE-4EE0-80AF-694E4D102130

P275

Q26749024-EAC8EB37-17A1-4BBA-827D-B4F911B5C552

P2860

Q26749024-0064B024-895E-4ADA-8372-CCAFC1B11938

Q26749024-07075E5F-2E00-4618-91C4-4892DBBE88DF

Q26749024-0E8B21BC-E926-4EF6-9EFC-EBCFFB458F6D

Q26749024-1290B6FD-3D51-49DD-A72B-D5BFB1649508

Q26749024-13E23A8E-532F-4207-9DC5-1A134DB73C8E

Q26749024-19210E82-303B-4447-B347-49A9AF3CF233

Q26749024-2546F5AC-C0A7-4CE0-9400-C57915737101

Q26749024-26E54854-D78B-4EB6-A8B3-7E534F9CE328

Q26749024-2C5F6EAE-E038-40D2-80F4-0F93916ADC75

Q26749024-2CE4466A-F4D6-4A1B-91E4-044D659AE44B

P2888

Q26749024-60183088-D20A-43E3-A824-11378F4F1A9F

P304

Q26749024-E5CD87CC-0F2D-4710-8769-33DA2F8FB433

P31

Q26749024-06053CA4-A8F7-4C53-A9F8-2FD68C9E1534

Q26749024-9DC74A46-CDEE-4091-91CD-2D4897CF12D8

P3181

Q26749024-18CA771B-812E-49A3-A523-48110925ADA4

P356

Q26749024-44E20021-DF2A-41F3-995D-34FBB82C8ABF

P407

Q26749024-C2A15A1F-7241-428A-9657-B49A4E294F2F

P433

Q26749024-828B0F1F-60CF-46D4-9691-91E32CDDBBE0

P478

Q26749024-F6C44F76-07DA-43A1-8D53-7887BDB74ADC

P50

Q26749024-0113692E-1D0D-4FB5-A2D8-6709E0DB2D31

Q26749024-BA06CD62-5353-476D-8833-ED26F4E80E23

P5008

Q26749024-904BF584-B914-434C-A540-A411A53C7641

P577

Q26749024-FA683680-C989-4CB5-BD2D-4F7B1FF9D65A

P6179

Q26749024-00206344-882B-450F-A10C-973D4782ED79

P698

Q26749024-7D945A6E-8074-40DB-9D38-2659D9ED0D67

P921

Q26749024-99CC9FC7-0AE9-44AB-BB5C-E8EE475AD643

Q26749024-9A2A3AE6-F00F-463C-A94C-444AA2FFC938

Q26749024-C03821F7-B0F3-4F04-927D-A139E5004430

P932

Q26749024-6CD31931-80BF-445B-89AE-27C978802886

P3181

P356

S12981-016-0105-Z

P1433

AIDS Research and Therapy

P1476

What happens to cardiovascular system behind the undetectable level of HIV viremia?

@en

P2093

Gabriella De Girolamo

http://www.w3.org/2001/XMLSchema#string

Ivan Schietroma

http://www.w3.org/2001/XMLSchema#string

Noemi Giustini

http://www.w3.org/2001/XMLSchema#string

Paolo Pavone

http://www.w3.org/2001/XMLSchema#string

Pietro Vittozzi

http://www.w3.org/2001/XMLSchema#string

Sara Serafino

http://www.w3.org/2001/XMLSchema#string

Vincenzo Vullo

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

HIV infection and the risk of acute myocardial infarction.

High levels of chronic immune activation in the T-cell compartments of patients coinfected with hepatitis C virus and human immunodeficiency virus type 1 and on highly active antiretroviral therapy are reverted by alpha interferon and ribavirin trea

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study.

Inflammation in atherosclerosis: from pathophysiology to practice

Soluble CD14 is independently associated with coronary calcification and extent of subclinical vascular disease in treated HIV infection.

HIV gp120 induces endothelial dysfunction in tumour necrosis factor-alpha-activated porcine and human endothelial cells

Endothelial dysfunction in chronic inflammatory diseases

Taming HIV-related inflammation with physical activity: a matter of timing

Reduction of immune activation with chloroquine therapy during chronic HIV infection

P2888

s12981-016-0105-z

P304

21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2044618

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/S12981-016-0105-Z

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Gabriella d'Ettorre

Giancarlo Ceccarelli

P5008

P577

2016-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1013533832

http://www.w3.org/2001/XMLSchema#string

P698

27127532

http://www.w3.org/2001/XMLSchema#string

P921

human immunodeficiency virus infectious disease

Retroviridae infectious disease

cardiovascular disease

P932

4848790

http://www.w3.org/2001/XMLSchema#string